z-logo
open-access-imgOpen Access
Disclosing Genetic Risk of Alzheimer’s Disease to Cognitively Unimpaired Older Adults: Findings from the Study of Knowledge and Reactions to APOE Testing (SOKRATES II)
Author(s) -
Emily A. Largent,
Twisha Bhardwaj,
Maramawit Abera,
Shana D. Stites,
Kristin Harkins,
Alan J. Lerner,
Angela R. Bradbury,
Jason Karlawish
Publication year - 2021
Publication title -
journal of alzheimer's disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.677
H-Index - 139
eISSN - 1875-8908
pISSN - 1387-2877
DOI - 10.3233/jad-210675
Subject(s) - apolipoprotein e , disease , psychology , perception , alzheimer's disease , stigma (botany) , clinical psychology , gerontology , medicine , psychiatry , pathology , neuroscience
Current practice guidelines recommend against Apolipoprotein E (APOE) testing. However, advances in Alzheimer's disease (AD) research and care may soon change this.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here